To obtain further information on the tolerability and efficacy of Atrovent® inhalets in long term treatment of Chronic Obstructive Pulmonary Disease under conditions of daily practice
Study Type
OBSERVATIONAL
Enrollment
595
Investigator assessment of improvement of the clinical picture rated on a 6-point symptom profile
Time frame: Up to 12 months after first study drug administration
Assessment of efficacy by investigator on a 4-point scale
Time frame: Up to 12 months after first study drug administration
Assessment of efficacy by patient on a 4-point scale
Time frame: Up to 12 months after first study drug administration
Assessment of tolerability by investigator on a 4-point scale
Time frame: Up to 12 months after first study drug administration
Assessment of tolerability by patient on a 4-point scale
Time frame: Up to 12 months after first study drug administration
Number of patients with adverse drug reactions
Time frame: Up to 12 months after first study drug administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.